A case against GenomeDx was brought alleging violations of the False Claims Act (FCA) and the California Insurance Claims Fraud Prevention Act regarding unnecessary services such as the testing of tissues that did not need to be tested.  The case resulted in a $350,000 whistleblower award.

$2 Million Dollar False Claims Act (FCA) Settlement – Unnecessary Services